Clinical Trial Update: Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients [Phase 2]

View source ↗

Summary

Phase 2 study comparing Sr-hGH to daily human growth hormone in idiopathic short stature to establish dosing and assess efficacy and safety; the trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Sr-hGH
• recombinant human growth hormone (somatropin) (somatropin)

Snippet

Sponsor: LG Life Sciences | Conditions: Establishing Dose of Sr-hGH in ISS Patients | Phase 2 | Status: COMPLETED